Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies.

SARS-CoV-2 copy-number variation immunoglobulin allelic diversity neutralizing antibody single-nucleotide polymorphism

Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
10 01 2023
Historique:
received: 28 05 2022
revised: 23 09 2022
accepted: 07 12 2022
pubmed: 28 12 2022
medline: 14 1 2023
entrez: 27 12 2022
Statut: ppublish

Résumé

The human immunoglobulin heavy-chain (IGH) locus is exceptionally polymorphic, with high levels of allelic and structural variation. Thus, germline IGH genotypes are personal, which may influence responses to infection and vaccination. For an improved understanding of inter-individual differences in antibody responses, we isolated SARS-CoV-2 spike-specific monoclonal antibodies from convalescent health care workers, focusing on the IGHV1-69 gene, which has the highest level of allelic variation of all IGHV genes. The IGHV1-69

Identifiants

pubmed: 36574772
pii: S1074-7613(22)00641-0
doi: 10.1016/j.immuni.2022.12.005
pmc: PMC9742198
pii:
doi:

Substances chimiques

Immunoglobulin Heavy Chains 0
Antibodies, Viral 0
Antibodies, Neutralizing 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

193-206.e7

Subventions

Organisme : Medical Research Council
ID : MR/W005611/1
Pays : United Kingdom

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests M. Corcoran and G.B.K.H. are founders of ImmuneDiscover Sweden.

Références

Sci Immunol. 2021 Aug 19;6(62):
pubmed: 34413140
Bioinformatics. 2019 Nov 1;35(22):4840-4842
pubmed: 31173062
Science. 2020 Aug 21;369(6506):956-963
pubmed: 32540903
Cell Rep Med. 2021 Nov 16;2(11):100450
pubmed: 34723224
Science. 2020 Aug 21;369(6506):1010-1014
pubmed: 32540901
Nature. 2020 Aug;584(7821):437-442
pubmed: 32555388
Science. 2020 Aug 28;369(6507):1119-1123
pubmed: 32661058
Nat Commun. 2021 Jun 21;12(1):3815
pubmed: 34155209
Nat Med. 2020 Sep;26(9):1422-1427
pubmed: 32651581
Cell. 2020 Jul 9;182(1):73-84.e16
pubmed: 32425270
Front Immunol. 2019 Apr 05;10:660
pubmed: 31024532
Cell. 2020 Aug 20;182(4):843-854.e12
pubmed: 32673567
J Exp Med. 2020 Feb 3;217(2):
pubmed: 31704807
Sci Adv. 2019 Jan 02;5(1):eaav1882
pubmed: 30613781
Genes Immun. 2021 Aug;22(4):205-217
pubmed: 34175903
Proc Natl Acad Sci U S A. 2015 Dec 22;112(51):E7118-27
pubmed: 26621739
Nat Methods. 2021 Jun;18(6):588-591
pubmed: 34002093
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
Cell Rep. 2021 May 11;35(6):109109
pubmed: 33932326
Nature. 2021 Dec;600(7889):517-522
pubmed: 34619745
PLoS Comput Biol. 2016 Sep 15;12(9):e1005117
pubmed: 27632220
Cell Host Microbe. 2022 Jan 12;30(1):69-82.e10
pubmed: 34973165
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Nat Immunol. 2021 Dec;22(12):1479-1489
pubmed: 34795445
Mol Immunol. 2017 Jul;87:12-22
pubmed: 28388445
Nat Commun. 2022 Aug 4;13(1):4539
pubmed: 35927266
Front Immunol. 2020 Sep 23;11:2136
pubmed: 33072076
Nature. 2022 Aug;608(7923):593-602
pubmed: 35714668
Sci Immunol. 2021 Feb 23;6(56):
pubmed: 33622975
Science. 2020 Sep 18;369(6510):1501-1505
pubmed: 32703906
Signal Transduct Target Ther. 2021 May 17;6(1):195
pubmed: 34001847
PLoS Pathog. 2014 May 01;10(5):e1004103
pubmed: 24788925
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Am J Hum Genet. 2013 Apr 4;92(4):530-46
pubmed: 23541343
Nat Rev Genet. 2014 Jun;15(6):379-93
pubmed: 24776769
J Immunol Methods. 2008 Jan 1;329(1-2):112-24
pubmed: 17996249
Sci Transl Med. 2021 Oct 20;13(616):eabj5413
pubmed: 34519517
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Biochem Biophys Res Commun. 2021 Jan 29;538:192-203
pubmed: 33069360
Nat Methods. 2019 Jul;16(7):595-602
pubmed: 31249422
Immunity. 2022 Feb 8;55(2):341-354.e7
pubmed: 34990590
Immunity. 2022 Jan 11;55(1):174-184.e5
pubmed: 35021055
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Genes Immun. 2012 Jul;13(5):363-73
pubmed: 22551722
Cell. 2021 Jun 10;184(12):3205-3221.e24
pubmed: 34015271
Nat Commun. 2020 Sep 4;11(1):4420
pubmed: 32887876
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Nat Commun. 2016 Dec 20;7:13642
pubmed: 27995928
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Sci Immunol. 2016 Dec 16;1(6):
pubmed: 28111638
Sci Immunol. 2021 Dec 10;6(66):eabl5842
pubmed: 34648356
Nature. 2020 Dec;588(7839):682-687
pubmed: 33045718
Sci Rep. 2016 Feb 16;6:20842
pubmed: 26880249
Nat Commun. 2019 Feb 7;10(1):628
pubmed: 30733445
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):
pubmed: 33593941
NPJ Vaccines. 2021 Sep 6;6(1):113
pubmed: 34489473
Sci Transl Med. 2021 May 12;13(593):
pubmed: 33820835
Immunity. 2020 Jul 14;53(1):98-105.e5
pubmed: 32561270
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
J Exp Med. 1998 Dec 7;188(11):2151-62
pubmed: 9841928
J Immunol. 1998 Dec 1;161(11):6068-73
pubmed: 9834090
Science. 2020 Aug 7;369(6504):643-650
pubmed: 32540902
Cell. 2020 Aug 20;182(4):828-842.e16
pubmed: 32645326
Immunity. 2021 Feb 9;54(2):355-366.e4
pubmed: 33484642
Nat Methods. 2019 Nov;16(11):1146-1152
pubmed: 31591575
RNA. 2003 Apr;9(4):493-501
pubmed: 12649500
Nat Commun. 2020 Nov 4;11(1):5588
pubmed: 33149112
Annu Rev Anal Chem (Palo Alto Calif). 2015;8:127-48
pubmed: 26048552
Immunity. 2022 Sep 13;55(9):1693-1709.e8
pubmed: 35952670
PLoS Comput Biol. 2021 Aug 3;17(8):e1009254
pubmed: 34343164
Sci Adv. 2022 Mar 25;8(12):eabm0220
pubmed: 35333580

Auteurs

Pradeepa Pushparaj (P)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Andrea Nicoletto (A)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Daniel J Sheward (DJ)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Hrishikesh Das (H)

Department of Cell and Molecular Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Xaquin Castro Dopico (X)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Laura Perez Vidakovics (L)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Leo Hanke (L)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Mark Chernyshev (M)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Sanjana Narang (S)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Sungyong Kim (S)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Julian Fischbach (J)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Simon Ekström (S)

Department of Biomedical Engineering, Lund University, 221 84 Lund, Sweden.

Gerald McInerney (G)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

B Martin Hällberg (BM)

Department of Cell and Molecular Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Ben Murrell (B)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Martin Corcoran (M)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.

Gunilla B Karlsson Hedestam (GB)

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden. Electronic address: gunilla.karlsson.hedestam@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH